Advertisement

Intensive Care Medicine

, Volume 42, Issue 3, pp 305–315 | Cite as

Organ donation in adults: a critical care perspective

  • Giuseppe CiterioEmail author
  • Marcelo Cypel
  • Geoff J. Dobb
  • Beatriz Dominguez-Gil
  • Jennifer A. Frontera
  • David M. Greer
  • Alex R. Manara
  • Sam D. Shemie
  • Martin Smith
  • Franco Valenza
  • Eelco F. M. Wijdicks
Review

Abstract

Purpose

The shortage of organs for transplantation is an important medical and societal problem because transplantation is often the best therapeutic option for end-stage organ failure.

Methods

We review the potential deceased organ donation pathways in adult ICU practice, i.e. donation after brain death (DBD) and controlled donation after circulatory death (cDCD), which follows the planned withdrawal of life-sustaining treatments (WLST) and subsequent confirmation of death using cardiorespiratory criteria.

Results

Strategies in the ICU to increase the number of organs available for transplantation are discussed. These include timely identification of the potential organ donor, optimization of the brain-dead donor by aggressive management of the physiological consequence of brain death, implementation of cDCD protocols, and the potential for ex vivo perfusion techniques.

Conclusions

Organ donation should be offered as a routine component of the end-of-life care plan of every patient dying in the ICU where appropriate, and intensivists are the key professional in this process.

Keywords

Organ donation Brain death Donation after brain death Donation after circulatory death Intensive care 

Notes

Compliance with ethical standards

Conflicts of interest

The authors declare no conflict of interest for this manuscript.

Supplementary material

134_2015_4191_MOESM1_ESM.docx (102 kb)
Supplementary material 1 (DOCX 102 kb)

References

  1. 1.
    Lesieur O, Leloup M, Gonzalez F, Mamzer M-F (2014) Eligibility for organ donation following end-of-life decisions: a study performed in 43 French intensive care units. Intensive Care Med. doi: 10.1007/s00134-014-3409-2 PubMedGoogle Scholar
  2. 2.
    Frontera JA, Curtis JR, Nelson JE et al (2015) Integrating palliative care into the care of neurocritically ill patients. Crit Care Med. doi: 10.1097/CCM.0000000000001131 PubMedPubMedCentralGoogle Scholar
  3. 3.
    Domínguez-Gil B, Murphy P, Procaccio F (2015) Ten changes that could improve organ donation in the intensive care unit. Intensive Care Med. doi: 10.1007/s00134-015-3833-y PubMedGoogle Scholar
  4. 4.
    Da Silva IRF, Frontera JA (2015) Worldwide barriers to organ donation. JAMA Neurol 72:112–118. doi: 10.1001/jamaneurol.2014.3083 PubMedGoogle Scholar
  5. 5.
    Wahlster S, Wijdicks EFM, Patel PV et al (2015) Brain death declaration: practices and perceptions worldwide. Neurology 84:1870–1879. doi: 10.1212/WNL.0000000000001540 PubMedPubMedCentralGoogle Scholar
  6. 6.
    Wijdicks EFM, Varelas PN, Gronseth GS et al (2010) Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74:1911–1918. doi: 10.1212/WNL.0b013e3181e242a8 PubMedGoogle Scholar
  7. 7.
    Wijdicks EFM (2002) Brain death worldwide: accepted fact but no global consensus in diagnostic criteria. Neurology 58:20–25PubMedGoogle Scholar
  8. 8.
    Citerio G, Crippa IA, Bronco A et al (2014) Variability in brain death determination in Europe: looking for a solution. Neurocrit Care 21:376–382. doi: 10.1007/s12028-014-9983-x PubMedGoogle Scholar
  9. 9.
    Greer DM, Varelas PN, Haque S, Wijdicks EFM (2008) Variability of brain death determination guidelines in leading US neurologic institutions. Neurology 70:284–289. doi: 10.1212/01.wnl.0000296278.59487.c2 PubMedGoogle Scholar
  10. 10.
    Shappell CN, Frank JI, Husari K et al (2013) Practice variability in brain death determination: a call to action. Neurology 81:2009–2014. doi: 10.1212/01.wnl.0000436938.70528.4a PubMedPubMedCentralGoogle Scholar
  11. 11.
    Powner DJ, Hernandez M, Rives TE (2004) Variability among hospital policies for determining brain death in adults. Crit Care Med 32:1284–1288PubMedGoogle Scholar
  12. 12.
    Hornby K, Shemie SD, Teitelbaum J, Doig C (2006) Variability in hospital-based brain death guidelines in Canada. Can J Anaesth 53:613–619. doi: 10.1007/BF03021854 PubMedGoogle Scholar
  13. 13.
    Citerio G, Murphy PG (2015) Brain death: the European perspective. Semin Neurol 35:139–144. doi: 10.1055/s-0035-1547533 PubMedGoogle Scholar
  14. 14.
    Haupt WF, Rudolf J (1999) European brain death codes: a comparison of national guidelines. J Neurol 246:432–437PubMedGoogle Scholar
  15. 15.
    Scott JB, Gentile MA, Bennett SN et al (2013) Apnea testing during brain death assessment: a review of clinical practice and published literature. Respir Care 58:532–538. doi: 10.4187/respcare.01962 PubMedGoogle Scholar
  16. 16.
    Shemie SD, Hornby L, Baker A et al (2014) International guideline development for the determination of death. Intensive Care Med 40:788–797. doi: 10.1007/s00134-014-3242-7 PubMedPubMedCentralGoogle Scholar
  17. 17.
    Shemie S, Baker A (2015) Uniformity in brain death criteria. Semin Neurol 35:162–168. doi: 10.1055/s-0035-1547538 PubMedGoogle Scholar
  18. 18.
    Shemie SD, Baker A (2014) Where have we been? Where are we going? Initiatives to improve uniformity of policies, integrity of practice, and improve understanding of brain death within the global medical community and lay public. J Crit Care 29:1114–1116. doi: 10.1016/j.jcrc.2014.08.007 PubMedGoogle Scholar
  19. 19.
    Gries CJ, White DB, Truog RD et al (2013) An Official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determination of death. Am J Respir Crit Care Med 188:103–109. doi: 10.1164/rccm.201304-0714ST PubMedGoogle Scholar
  20. 20.
    Dalal AR (2015) Philosophy of organ donation: review of ethical facets. World J Transpl 5:44–51. doi: 10.5500/wjt.v5.i2.44 Google Scholar
  21. 21.
    Shaw D (2015) Organ donation is the right decision: a delicate truth. Intensive Care Med. doi: 10.1007/s00134-015-3891-1 PubMedGoogle Scholar
  22. 22.
    Shemie SD (2007) Clarifying the paradigm for the ethics of donation and transplantation: was “dead” really so clear before organ donation? Philos Ethics Humanit Med 2:18. doi: 10.1186/1747-5341-2-18 PubMedPubMedCentralGoogle Scholar
  23. 23.
    Sixty-Third World Health Assembly World Health Organization (2010) WHO guiding principles on human cell, tissue and organ transplantation. Cell Tissue Bank 11:413–419Google Scholar
  24. 24.
    Steinbrook R (2007) Organ donation after cardiac death. N Engl J Med 357:209–213. doi: 10.1056/NEJMp078066 PubMedGoogle Scholar
  25. 25.
    Bernat JL (2008) The boundaries of organ donation after circulatory death. N Engl J Med 359:669–671. doi: 10.1056/NEJMp0804161 PubMedGoogle Scholar
  26. 26.
    Morrissey PE, Monaco AP (2014) Donation after circulatory death: current practices, ongoing challenges, and potential improvements. Transplantation 97:258–264. doi: 10.1097/01.TP.0000437178.48174.db PubMedGoogle Scholar
  27. 27.
    Domínguez-Gil B, Haase-Kromwijk B, Van Leiden H et al (2011) Current situation of donation after circulatory death in European countries. Transpl Int 24:676–686. doi: 10.1111/j.1432-2277.2011.01257.x PubMedGoogle Scholar
  28. 28.
    Borry P, Van Reusel W, Roels L, Schotsmans P (2008) Donation after uncontrolled cardiac death (uDCD): a review of the debate from a European perspective. J Law Med Ethics 36:752–759. doi: 10.1111/j.1748-720X.2008.00334.x PubMedGoogle Scholar
  29. 29.
    Bernat JL, Bleck TP, Blosser SA et al (2014) Circulatory death determination in uncontrolled organ donors: a panel viewpoint. Ann Emerg Med 63:384–390. doi: 10.1016/j.annemergmed.2013.05.018 PubMedGoogle Scholar
  30. 30.
    Simpkin AL, Robertson LC, Barber VS, Young JD (2009) Modifiable factors influencing relatives’ decision to offer organ donation: systematic review. BMJ 338:b991–b991. doi: 10.1136/bmj.b991 PubMedPubMedCentralGoogle Scholar
  31. 31.
    Singbartl K, Murugan R, Kaynar AM et al (2011) Intensivist-led management of brain-dead donors is associated with an increase in organ recovery for transplantation. Am J Transpl 11:1517–1521. doi: 10.1111/j.1600-6143.2011.03485.x Google Scholar
  32. 32.
    Bastami S, Matthes O, Krones T, Biller-Andorno N (2013) Systematic review of attitudes toward donation after cardiac death among healthcare providers and the general public. Crit Care Med 41:897–905. doi: 10.1097/CCM.0b013e31827585fe PubMedGoogle Scholar
  33. 33.
    Manara AR, Murphy PG, O’Callaghan G (2011) Donation after circulatory death. Br J Anaesth 108:i108–i121. doi: 10.1093/bja/aer357 Google Scholar
  34. 34.
    Souter MJ, Blissitt PA, Blosser S et al (2015) Recommendations for the critical care management of devastating brain injury: prognostication, psychosocial, and ethical management. Neurocrit Care 23:4–13. doi: 10.1007/s12028-015-0137-6 PubMedGoogle Scholar
  35. 35.
    Mark NM, Rayner SG, Lee NJ, Curtis JR (2015) Global variability in withholding and withdrawal of life-sustaining treatment in the intensive care unit: a systematic review. Intensive Care Med. doi: 10.1007/s00134-015-3810-5 PubMedGoogle Scholar
  36. 36.
    Sprung CL, Cohen SL, Sjokvist P et al (2003) End-of-life practices in European intensive care units: the Ethicus Study. JAMA 290:790–797. doi: 10.1001/jama.290.6.790 PubMedGoogle Scholar
  37. 37.
    Patel S, Martin JR, Marino PS (2014) Donation after circulatory death. Crit Care Med 42:2219–2224. doi: 10.1097/CCM.0000000000000511 PubMedGoogle Scholar
  38. 38.
    Algahim MF, Love RB (2015) Donation after circulatory death. Current Opinion Organ Transpl 20:1–6. doi: 10.1097/MOT.0000000000000179 Google Scholar
  39. 39.
    McKeown DW, Bonser RS, Kellum JA (2011) Management of the heartbeating brain-dead organ donor. Br J Anaesth 108:i96–i107. doi: 10.1093/bja/aer351 Google Scholar
  40. 40.
    Youn TS, Greer DM (2014) Brain death and management of a potential organ donor in the intensive care unit. Crit Care Clin 30:813–831. doi: 10.1016/j.ccc.2014.06.010 PubMedGoogle Scholar
  41. 41.
    Smith M (2004) Physiologic changes during brain stem death-lessons for management of the organ donor. J Heart Lung Transpl 23:S217–S222. doi: 10.1016/j.healun.2004.06.017 Google Scholar
  42. 42.
    Kotloff RM, Blosser S, Fulda GJ et al (2015) Management of the potential organ donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations consensus statement. Crit Care Med 43:1291–1325. doi: 10.1097/CCM.0000000000000958 PubMedGoogle Scholar
  43. 43.
    Al-Khafaji A, Elder M, Lebovitz DJ et al (2015) Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial. Intensive Care Med. doi: 10.1007/s00134-014-3621-0 PubMedPubMedCentralGoogle Scholar
  44. 44.
    Greer DM, Valenza F, Citerio G (2015) Improving donor management and transplantation success: more research is needed. Intensive Care Med. doi: 10.1007/s00134-015-3661-0 PubMedGoogle Scholar
  45. 45.
    Dupuis S, Amiel J-A, Desgroseilliers M et al (2014) Corticosteroids in the management of brain-dead potential organ donors: a systematic review. Br J Anaesth 113:346–359. doi: 10.1093/bja/aeu154 PubMedGoogle Scholar
  46. 46.
    Pinsard M, Ragot S, Mertes PM et al (2014) Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: the CORTICOME study. Crit Care 18:R158. doi: 10.1186/cc13997 PubMedPubMedCentralGoogle Scholar
  47. 47.
    Macdonald PS, Aneman A, Bhonagiri D et al (2012) A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors. Crit Care Med 40:1635–1644. doi: 10.1097/CCM.0b013e3182416ee7 PubMedGoogle Scholar
  48. 48.
    Mascia L, Mastromauro I, Viberti S et al (2009) Management to optimize organ procurement in brain dead donors. Minerva Anestesiol 75:125–133. doi: 10.2147/CLEP.S71403 PubMedGoogle Scholar
  49. 49.
    Mascia L, Pasero D, Slutsky AS et al (2010) Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA 304:2620–2627. doi: 10.1001/jama.2010.1796 PubMedGoogle Scholar
  50. 50.
    Niemann CU, Feiner J, Swain S et al (2015) Therapeutic hypothermia in deceased organ donors and kidney-graft function. N Engl J Med 373:405–414. doi: 10.1056/NEJMoa1501969 PubMedGoogle Scholar
  51. 51.
    Dikdan GS, Mora-Esteves C, Koneru B (2012) Review of randomized clinical trials of donor management and organ preservation in deceased donors. Transplantation. doi: 10.1097/TP.0b013e3182547537 Google Scholar
  52. 52.
    Dhital KK, Iyer A, Connellan M et al (2015) Adult heart transplantation with distant procurement and ex vivo preservation of donor hearts after circulatory death: a case series. Lancet. doi: 10.1016/S0140-6736(15)60038-1 Google Scholar
  53. 53.
    Cypel M, Yeung JC, Liu M et al (2011) Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 364:1431–1440. doi: 10.1056/NEJMoa1014597 PubMedGoogle Scholar
  54. 54.
    Cypel M, Yeung JC, Hirayama S et al (2008) Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transpl 27:1319–1325. doi: 10.1016/j.healun.2008.09.003 Google Scholar
  55. 55.
    Machuca TN, Mercier O, Collaud S et al (2015) Lung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusion. Am J Transpl 15:993–1002. doi: 10.1111/ajt.13124 Google Scholar
  56. 56.
    Reeb J, Keshavjee S, Cypel M (2015) Expanding the lung donor pool: advancements and emerging pathways. Current Opinion Organ Transpl. doi: 10.1097/MOT.0000000000000233 PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg and ESICM 2015

Authors and Affiliations

  • Giuseppe Citerio
    • 1
    • 2
    Email author
  • Marcelo Cypel
    • 3
  • Geoff J. Dobb
    • 4
    • 5
  • Beatriz Dominguez-Gil
    • 6
  • Jennifer A. Frontera
    • 7
  • David M. Greer
    • 8
  • Alex R. Manara
    • 9
  • Sam D. Shemie
    • 10
  • Martin Smith
    • 11
    • 12
  • Franco Valenza
    • 13
  • Eelco F. M. Wijdicks
    • 14
  1. 1.School of Medicine and SurgeryUniversity of Milan-BicoccaMilanItaly
  2. 2.Neurointensive Care, Department of Emergency and Intensive CareSan Gerardo HospitalMonzaItaly
  3. 3.Division of Thoracic SurgeryUniversity of TorontoTorontoCanada
  4. 4.Intensive Care UnitRoyal Perth HospitalPerthAustralia
  5. 5.School of Medicine and PharmacologyUniversity of Western AustraliaPerthAustralia
  6. 6.Organización Nacional de TrasplantesMadridSpain
  7. 7.Cerebrovascular Center of the Neurological InstituteCleveland ClinicClevelandUSA
  8. 8.Department of NeurologyYale University School of MedicineNew HavenUSA
  9. 9.The Intensive Care UnitSouthmead Hospital, North Bristol NHS TrustBristolUK
  10. 10.Division of Critical Care, Montreal Children’s HospitalMcGill University Health CentreMontrealCanada
  11. 11.Department of Neurocritical Care, National Hospital for Neurology and NeurosurgeryUniversity College London HospitalsLondonUK
  12. 12.National Institute for Health Research UCLH Biomedical Research CentreLondonUK
  13. 13.Department of Pathophysiology and TransplantationUniversity of MilanMilanItaly
  14. 14.Division of Critical Care Neurology, Department of NeurologyMayo ClinicRochesterUSA

Personalised recommendations